Abbott Laboratories Valuation
| ABL Stock | 109.66 1.56 1.44% |
At this time, the firm appears to be overvalued. Abbott Laboratories shows a prevailing Real Value of USD93.21 per share. The current price of the firm is USD109.66. Our model approximates the value of Abbott Laboratories from analyzing the firm fundamentals such as return on equity of 0.19, and Profit Margin of 0.16 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Abbott Laboratories' price fluctuation is very steady at this time. Calculation of the real value of Abbott Laboratories is based on 3 months time horizon. Increasing Abbott Laboratories' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Abbott Laboratories' intrinsic value may or may not be the same as its current market price of 109.66, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 109.66 | Real 93.21 | Hype 109.66 | Naive 109.73 |
The intrinsic value of Abbott Laboratories' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Abbott Laboratories' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Abbott Laboratories helps investors to forecast how Abbott stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Abbott Laboratories more accurately as focusing exclusively on Abbott Laboratories' fundamentals will not take into account other important factors: Abbott Laboratories Total Value Analysis
Abbott Laboratories is presently expected to have takeover price of 183.73 B with market capitalization of 165.42 B, debt of 14.52 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Abbott Laboratories fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
183.73 B | 165.42 B | 14.52 B |
Abbott Laboratories Investor Information
About 76.0% of the company shares are held by institutions such as insurance companies. The company last dividend was issued on the 13th of April 2023. Based on the key indicators related to Abbott Laboratories' liquidity, profitability, solvency, and operating efficiency, Abbott Laboratories is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.Abbott Laboratories Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Abbott Laboratories has an asset utilization ratio of 58.64 percent. This implies that the Company is making USD0.59 for each dollar of assets. An increasing asset utilization means that Abbott Laboratories is more efficient with each dollar of assets it utilizes for everyday operations.Abbott Laboratories Ownership Allocation
Abbott Laboratories holds a total of 1.74 Billion outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Abbott Laboratories Profitability Analysis
The company reported the revenue of 43.65 B. Net Income was 6.93 B with profit before overhead, payroll, taxes, and interest of 24.58 B.About Abbott Laboratories Valuation
The stock valuation mechanism determines Abbott Laboratories' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Abbott Laboratories based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Abbott Laboratories. We calculate exposure to Abbott Laboratories's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Abbott Laboratories's related companies.8 Steps to conduct Abbott Laboratories' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Abbott Laboratories' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Abbott Laboratories' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Abbott Laboratories' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Abbott Laboratories' revenue streams: Identify Abbott Laboratories' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Abbott Laboratories' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Abbott Laboratories' growth potential: Evaluate Abbott Laboratories' management, business model, and growth potential.
- Determine Abbott Laboratories' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Abbott Laboratories' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.